| Not Yet Recruiting | Prospective Clinical Study, Using a Medical Device (RepHegyn) as an Adjuvant in the Treatment of Fungal (Candi NCT07367295 | Innate srl | — |
| Not Yet Recruiting | Viromes in Infants Presenting With a Septic Syndrome NCT07470541 | University Hospital, Montpellier | N/A |
| Recruiting | A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Heal NCT07017777 | CanSino Biologics Inc. | Phase 3 |
| Recruiting | A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants Wi NCT07104162 | Qpex Biopharma, Inc. | Phase 1 |
| Enrolling By Invitation | Diagnostic Application of AI-ROSE in Severe Pneumonia NCT07113951 | The First Affiliated Hospital with Nanjing Medical University | — |
| Recruiting | Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers NCT07207291 | Joincare Pharmaceutical Group Industry Co., Ltd | Phase 1 |
| Not Yet Recruiting | Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis NCT07062445 | Hospital Israelita Albert Einstein | — |
| Not Yet Recruiting | Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacteri NCT07146217 | Saptalis Pharmaceuticals LLC | Phase 2 |
| Not Yet Recruiting | The AcCREDiT 2 Study NCT07029672 | Manchester University NHS Foundation Trust | — |
| Recruiting | Monotherapy vs Combination Therapy for Bone Infections Caused by Pseudomonas Aeruginosa NCT07056881 | Centre Hospitalier de Saint-Denis | — |
| Active Not Recruiting | A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women NCT06592586 | Minervax ApS | Phase 2 / Phase 3 |
| Not Yet Recruiting | A Cluster Randomized Controlled Trial to Compare the Rate of Antibiotic Infusion NCT06620341 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Completed | PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment NCT06157242 | Qpex Biopharma, Inc. | Phase 1 |
| Completed | A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Par NCT06547554 | Qpex Biopharma, Inc. | Phase 1 |
| Recruiting | Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective End NCT06704048 | Region Halland | N/A |
| Recruiting | Comparison of Salivary Procalcitonin (PCT) Levels and Serum PCT Levels NCT06354205 | Ege University | N/A |
| Recruiting | Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis NCT06103500 | Ottawa Hospital Research Institute | N/A |
| Unknown | Effect of PreforPro® on Urinary and Vaginal Health NCT05590195 | Jeremy Burton | Phase 3 |
| Not Yet Recruiting | Self-administration in Outpatient Parenteral Antimicrobial Therapy Service NCT06404307 | Erasmus Medical Center | N/A |
| Recruiting | Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO NCT06025682 | Gruppo Italiano Malattie EMatologiche dell'Adulto | — |
| Enrolling By Invitation | Application of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnosti NCT06995846 | Beijing YouAn Hospital | — |
| Completed | P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participan NCT06079775 | Qpex Biopharma, Inc. | Phase 1 |
| Completed | Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid NCT05611905 | Johns Hopkins University | — |
| Recruiting | Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in I NCT05783661 | Eva Bonfill | Phase 4 |
| Completed | Effect of Bifidobacterium Breve PRL2020 (an Amoxicillin-clavulanate-resistant Strain) on Gastrointestinal Symp NCT05840588 | Liaquat University of Medical & Health Sciences | N/A |
| Unknown | Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® NCT06319235 | MB PHARMA s.r.o. | Phase 1 / Phase 2 |
| Recruiting | Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens NCT06554145 | GramEye | — |
| Recruiting | Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image A NCT06519032 | GramEye | — |
| Completed | Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of NCT05684705 | BioVersys AG | Phase 1 |
| Terminated | The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Ad NCT05942820 | Bugworks Research Inc. | Phase 1 |
| Completed | A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection NCT05584683 | Kaizen Bioscience Co. | Phase 1 |
| Completed | Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirica NCT06174519 | Pragmatech AI Solutions | — |
| Active Not Recruiting | TDM-optimized Teicoplanin Dosing Versus Standard of Care NCT05914467 | Radboud University Medical Center | Phase 4 |
| Completed | VAT-2: Evaluation of a Virtual Antimicrobial Stewardship Team (VAT) on Antibiotic Prescriptions in Nursing Hom NCT05998226 | Public Health Service of Amsterdam | N/A |
| Completed | Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-Africa NCT05722184 | Institute of Tropical Medicine, Belgium | — |
| Completed | Monolaurin Ointment Versus Mupirocin Ointment NCT06046937 | Victoriano Luna Medical Center | EARLY_Phase 1 |
| Completed | Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO NCT05897801 | Hellenic Institute for the Study of Sepsis | — |
| Recruiting | Development and Accuracy Evaluation of Gram Staining Analysis AI NCT06377592 | GramEye | — |
| Recruiting | Impact of Procalcitonin-guided Algorithm on Early Discontinuation of Antibiotic Therapy NCT05350813 | University Hospital, Toulouse | N/A |
| Recruiting | Emergency PWAS in Respiratory Infectious Disease NCT05336851 | The University of Hong Kong | — |
| Unknown | Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections NCT05942157 | Singapore General Hospital | N/A |
| Unknown | A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021 NCT05762094 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | — |
| Unknown | Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation NCT05960383 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Completed | To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100 NCT05684718 | BioVersys AG | Phase 1 |
| Completed | Hydrogen Peroxide Fumigation in Dental Office Environment NCT06100848 | Wroclaw Medical University | N/A |
| Recruiting | A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+ NCT05645107 | Grifols Therapeutics LLC | Phase 3 |
| Completed | A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infecti NCT05614895 | Hoffmann-La Roche | Phase 1 |
| Completed | Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis NCT05641025 | Hospital Italiano de Buenos Aires | — |
| Unknown | Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healt NCT05587283 | AtoGen Co. Ltd | Phase 1 |
| Withdrawn | Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections NCT05269121 | Adaptive Phage Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Febrile Infant Diagnostic Assessment and Outcome Study NCT05259683 | Queen's University, Belfast | — |
| Completed | An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infec NCT06211829 | Methodist Health System | — |
| Completed | Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bac NCT05217537 | Paratek Pharmaceuticals Inc | Phase 1 |
| Unknown | Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseud NCT05285046 | D'Or Institute for Research and Education | — |
| Completed | Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjec NCT05226923 | Sumitovant Biopharma, Inc. | Phase 1 |
| Completed | Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects NCT05072444 | Qpex Biopharma, Inc. | Phase 1 |
| Completed | A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volun NCT05088421 | Bugworks Research Inc. | Phase 1 |
| Completed | Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED NCT05586438 | Mahidol University | Phase 4 |
| Completed | AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illnes NCT07205575 | Qilu Hospital of Shandong University | — |
| Completed | SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers NCT04808414 | Qpex Biopharma, Inc. | Phase 1 |
| Completed | RBG: Regular, Bare, Gel: Does Type of Nail Polish Affect Bacterial Counts After Surgical Scrubbing? NCT05210920 | University of North Carolina, Chapel Hill | N/A |
| Unknown | Use of Low-cost Molecular Diagnostic Techniques as a New Surveillance Model for Diseases Preventable by Vaccin NCT06322277 | Meyer Children's Hospital IRCCS | N/A |
| Unknown | Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing. NCT04864873 | Capital and Coast District Health board | N/A |
| Completed | Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults NCT04578873 | Qpex Biopharma, Inc. | Phase 1 |
| Completed | Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) NCT04841369 | CanSino Biologics Inc. | Phase 3 |
| Completed | Frequence of Dressing Change and Bacterial Colonization in Pediatric Intensive Care Unit NCT04806776 | Children's Hospital of Fudan University | N/A |
| Terminated | PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis NCT04783727 | Research Center Borstel | N/A |
| Completed | Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects NCT04802863 | Evopoint Biosciences Inc. | Phase 1 |
| Completed | To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males NCT04801043 | Evopoint Biosciences Inc. | Phase 1 |
| Completed | Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal Function NCT04787562 | Evopoint Biosciences Inc. | Phase 1 |
| Completed | The Role of Lactate in Viral and Bacterial Infection NCT04777747 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | — |
| Completed | P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV NCT04380207 | Qpex Biopharma, Inc. | Phase 1 |
| Withdrawn | Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life H NCT04226001 | Hospices Civils de Lyon | — |
| Recruiting | International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections NCT06634940 | Hospital Italiano de Buenos Aires | — |
| Withdrawn | The Study on Bacterial Load Following Open-to-air Management in Burn Patients. NCT04502914 | Texas Tech University Health Sciences Center | N/A |
| Completed | Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COV NCT05293418 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Completed | Blood Volume Assessment in COVID-19 and Bacterial Sepsis NCT04517695 | NYU Langone Health | — |
| Completed | Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/ NCT04482569 | Evopoint Biosciences Inc. | Phase 1 |
| Completed | Compliance With AntibIotic TherapY Guidelines in French PICUs NCT04642560 | University Hospital, Toulouse | — |
| Completed | Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above NCT04100772 | CanSino Biologics Inc. | Phase 1 |
| Completed | Host RNA Profiles to Detect Infections in Young Infants NCT04823026 | Rigshospitalet, Denmark | — |
| Completed | The Association of Gene Polymorphisms With Invasive Bacterial Infections in Neonates and Young Infants NCT06985160 | Ege University | N/A |
| Active Not Recruiting | Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo) NCT06419426 | Associazione Italiana Ematologia Oncologia Pediatrica | — |
| Completed | Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resist NCT03896685 | Médecins Sans Frontières, France | Phase 3 |
| Completed | Febrile Infants - Diagnostic Assessment and Outcome NCT04196192 | Belfast Health and Social Care Trust | — |
| Recruiting | [18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human S NCT04263792 | University of Pennsylvania | Phase 1 |
| Terminated | Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing NCT03271580 | Indiana University | — |
| Enrolling By Invitation | LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System NCT04633603 | University of Pecs | — |
| Completed | Pharmacokinetics of Teicoplanin in Intensive Care and Haematology Patients NCT04096092 | Radboud University Medical Center | — |
| Completed | Developing a Risk Assessment System of Multidrug-resistant Organisms Infection NCT04688216 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Unknown | Nudging Effect of Timer on Surgical Rub NCT04609384 | Sygehus Lillebaelt | — |
| Completed | Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan NCT05106803 | Yarmouk University | — |
| Unknown | Study to Optimize the Use of New Antibiotics NCT03941951 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | N/A |
| Completed | Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial NCT03925480 | Murdoch Childrens Research Institute | Phase 3 |
| Unknown | A Single Ascending Dose Study of AV-006 in Healthy Subjects NCT03931876 | Arixa Pharmaceuticals | Phase 1 |
| Completed | Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects NCT03939429 | Qpex Biopharma, Inc. | Phase 1 |
| Unknown | Effectiveness of a Hydrophobic Dressing for Microorganisms' Colonization and Infection Control of Vascular Ulc NCT03667937 | University of Malaga | Phase 4 |
| Unknown | Clinical Impact of 16S rDNA PCR NCT03915275 | University Hospital, Strasbourg, France | — |
| Unknown | Therapeutic Drug Monitoring of Teicoplanin in Children NCT03933748 | Shandong University | — |
| Completed | Clinical Impact of Rapid AST Directly From Blood Cultures NCT03992703 | Fondation Hôpital Saint-Joseph | — |
| Unknown | Infections Following NeuroSurgery (INS) NCT03857295 | Neuromed IRCCS | — |
| Unknown | Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections NCT03846921 | Hillel Yaffe Medical Center | — |
| Completed | Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients NCT03738683 | Radboud University Medical Center | — |
| Completed | Nurse Promotion of IV to PO Antimicrobial Conversion NCT03761043 | Kelowna General Hospital | N/A |
| Completed | A Safety and PK Study of IV Eravacycline NCT03696550 | Tetraphase Pharmaceuticals, Inc | Phase 1 |
| Terminated | Xydalba Utilization Registry in Germany NCT03696901 | Correvio International Sarl | — |
| Completed | Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological Characteristics NCT03919032 | Hospital Italiano de Buenos Aires | — |
| Unknown | Serum Ceftazidime Concentrations in Hemodialysis Patients NCT03634904 | Centre Hospitalier Universitaire de Charleroi | N/A |
| Completed | Xydalba Utilization Registry in France NCT03726216 | Correvio International Sarl | — |
| Unknown | PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients NCT03858387 | Prince of Songkla University | — |
| Completed | Controlled Human Infection for Vaccination Against Streptococcus Pyogenes NCT03361163 | Andrew Steer | Phase 1 |
| Recruiting | Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD NCT02655302 | University Hospital, Lille | N/A |
| Unknown | Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage NCT04328051 | University of Barcelona | N/A |
| Completed | A Single Ascending Dose Study of BTZ043 NCT03590600 | Michael Hoelscher | Phase 1 |
| Completed | Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs NCT03767374 | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | — |
| Completed | A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study NCT03450187 | Tetraphase Pharmaceuticals, Inc | Phase 1 |
| Completed | Effect of Passive Ultrasonic Irrigation on Bacteria That Persist After Root Canal Preparation NCT05100433 | University of Sao Paulo | N/A |
| Completed | 11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects NCT03424525 | University of Pennsylvania | Phase 1 |
| Completed | Direct Molecular Characterization of Bacteria From ICU and From the REHAB NCT03475472 | University Hospital, Basel, Switzerland | — |
| Active Not Recruiting | Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundan NCT06838780 | Chinese University of Hong Kong | — |
| Completed | Interest of Eosinopenia to Predict In-hospital Mortality Among Elderly Patients NCT04734431 | Centre d'Investigation Clinique et Technologique 805 | — |
| Completed | VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers NCT03332732 | Venatorx Pharmaceuticals, Inc. | Phase 1 |
| Completed | OR PathTrac (Tracking Intra-operative Bacterial Transmission) NCT03605498 | Sundara Reddy | — |
| Unknown | Efficacy and Safety of Colistin Based Antibiotic Therapy NCT04764058 | Ain Shams University | Phase 1 / Phase 2 |
| Completed | A Phase 1 Safety and PK Study of IV TP-271 NCT03234738 | Tetraphase Pharmaceuticals, Inc | Phase 1 |
| Completed | Adjunctive Steps for Disinfection of Teeth With Primary Endodontic Infections NCT03537664 | University of Sao Paulo | N/A |
| Completed | Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABS NCT03233438 | Allergan | Phase 4 |
| Unknown | Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury NCT03204591 | The Zhejiang Study Group for Organ Failure in Cirrhosis | — |
| Completed | A Rapid Test for Acute Respiratory Illness NCT03192072 | Duke University | — |
| Completed | Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients NCT02993575 | Radboud University Medical Center | — |
| Completed | Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Susp NCT02814916 | AbbVie | Phase 3 |
| Unknown | Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiri NCT03243864 | Temple University | — |
| Completed | A Phase 1 TP-271 Oral PK Single Ascending Dose Study NCT03024034 | Tetraphase Pharmaceuticals, Inc | Phase 1 |
| Completed | Pharmacokinetics of Ciprofloxacin in Critically Ill Patients NCT03016845 | Radboud University Medical Center | — |
| Completed | Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF NCT04358991 | University of Pittsburgh | — |
| Recruiting | Fosfomycin I.v. for Treatment of Severely Infected Patients NCT02979951 | Infectopharm Arzneimittel GmbH | — |
| Terminated | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antib NCT02527681 | Basilea Pharmaceutica | Phase 1 |
| Completed | VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers NCT02955459 | Venatorx Pharmaceuticals, Inc. | Phase 1 |
| Completed | Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplanta NCT03627000 | Hospices Civils de Lyon | — |
| Completed | Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP) NCT03053258 | Landon Pediatric Foundation | — |
| Completed | Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI NCT02877927 | Paratek Pharmaceuticals Inc | Phase 3 |
| Unknown | The Search for Viral and Bacterial Etiology of Varicocele NCT03079609 | Medical University of Warsaw | N/A |
| Active Not Recruiting | Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections NCT02687906 | Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) | Phase 1 |
| Completed | Multi-Drug Resistant Organism Network NCT03646227 | Duke University | — |
| Unknown | A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-resp NCT04254991 | MeMed Diagnostics Ltd. | — |
| Terminated | Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacteria NCT02688790 | AbbVie | Phase 1 |
| Completed | The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections NCT02848534 | Centre Hospitalier Universitaire, Amiens | — |
| Completed | Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carb NCT02852902 | Spanish Network for Research in Infectious Diseases | — |
| Unknown | Preauthorization Versus Prospective Audit in Antimicrobial Stewardship Program NCT02837081 | Kaohsiung Veterans General Hospital. | N/A |
| Completed | PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children NCT02475876 | Michael Cohen-Wolkowiez | Phase 1 |
| Completed | Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli NCT02541695 | NIZO Food Research | N/A |
| Completed | Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilasta NCT02452047 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | ANti-infective Stewardship Using the Wisca Tool in the Electronic Medical Record NCT03397433 | Endeavor Health | N/A |
| Completed | Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) NCT02378480 | Paratek Pharmaceuticals Inc | Phase 3 |
| Completed | Study of Debio 1450 for Bacterial Skin Infections NCT02426918 | Debiopharm International SA | Phase 2 |
| Completed | MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection NCT02269319 | MicuRx | Phase 2 |
| Completed | MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial NCT02306330 | Oxford University Clinical Research Unit, Vietnam | N/A |
| Completed | A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers NCT02214433 | Debiopharm International SA | Phase 1 |
| Completed | Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. NCT02146209 | Verisfield UK Ltd. Greek Branch | Phase 1 |
| Completed | A Single Dose Study of Debio 1450 in Healthy Subjects NCT02162199 | Debiopharm International SA | Phase 1 |
| Completed | To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy NCT02361866 | Green Cross Corporation | Phase 3 |
| Completed | A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595 NCT02134834 | Meiji Seika Pharma Co., Ltd. | Phase 1 |
| Completed | Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid NCT02066402 | Bayer | Phase 3 |
| Completed | Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents NCT01966055 | Melinta Therapeutics, Inc. | Phase 1 |
| Completed | TD-1607 MAD Study in Healthy Subjects NCT01949103 | Theravance Biopharma | Phase 1 |
| Completed | Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects NCT01897779 | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | Phase 1 |
| Completed | Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile NCT01744730 | Phillip Brian Smith | Phase 1 |
| Completed | A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Age NCT01946568 | Durata Therapeutics Inc., an affiliate of Allergan plc | Phase 1 |
| Completed | Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) NCT01839188 | MCM Vaccines B.V. | Phase 3 |
| Completed | Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in H NCT01839175 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination NCT01772836 | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | Phase 1 |
| Terminated | Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients. NCT02031588 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Pat NCT01746654 | GangaGen, Inc. | Phase 1 / Phase 2 |
| Completed | Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects NCT01751269 | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | Phase 1 |
| Completed | Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients NCT02294695 | Domonkos Trásy | — |
| Completed | Study of Complication Rates Associated With PICC for Left vs Right NCT01638702 | Richard Lindsay | N/A |
| Completed | Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software NCT01932034 | Children's Hospital Los Angeles | — |
| Unknown | Children's Antibiotic Resistant Infections in Low Income Countries NCT02074865 | Institut Pasteur | — |
| Completed | To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) NCT01689207 | Pfizer | Phase 1 |
| Completed | Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects NCT01702649 | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | Phase 1 |
| Completed | Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects NCT01608815 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) NCT01553279 | MCM Vaccines B.V. | Phase 3 |
| Completed | Effect of Xylitol on Oral Microbiota in Children NCT01528969 | Kuwait University | Phase 1 / Phase 2 |
| Completed | Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V NCT01480258 | MCM Vaccines B.V. | Phase 3 |
| Completed | Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative P NCT01412801 | Novartis Vaccines | Phase 2 |
| Completed | To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy C NCT01402713 | Green Cross Corporation | Phase 2 / Phase 3 |
| Unknown | Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) NCT00945152 | Robert S Berman MD | Phase 2 |
| Completed | Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419- NCT01341639 | MCM Vaccines B.V. | Phase 3 |
| Completed | A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) NCT01340937 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) NCT01337167 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy NCT01819298 | Far Eastern Memorial Hospital | — |
| Unknown | The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children NCT01159470 | Shaare Zedek Medical Center | — |
| Completed | Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial NCT01119105 | Nabriva Therapeutics AG | Phase 2 |
| Completed | Hospital Wide Roll-Out of Antimicrobial Stewardship NCT01587937 | Sunnybrook Health Sciences Centre | N/A |
| Completed | Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods NCT01111864 | Swiss Federal Institute of Technology | N/A |
| Completed | An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults NCT01018641 | Pfizer | Phase 1 |
| Completed | A Study of Doripenem in Infants Less Than 12 Weeks of Age NCT01381848 | Janssen Research & Development, LLC | Phase 1 |
| Completed | Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan) NCT00998309 | Pfizer | — |
| Completed | Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) NCT00983255 | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 1 |
| Completed | A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdomina NCT00965848 | Janssen-Cilag Ltd.,Thailand | Phase 4 |
| Completed | Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule NCT01058824 | Pfizer | Phase 1 |
| Completed | Regenerative Surgical Treatment of Peri-implantitis NCT02500654 | Catrine Isehed | Phase 4 |
| Completed | A Study To Assess The Effect Of Linezolid On QTc Interval NCT00795145 | Pfizer | Phase 1 |
| Terminated | Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflam NCT00835783 | Odense University Hospital | — |
| Completed | Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For NCT00678106 | Pfizer | Phase 1 |
| Completed | French Study In ICU Patients Treated With Tigecycline NCT00799591 | Wyeth is now a wholly owned subsidiary of Pfizer | — |
| Completed | Procalcitonin Level and Kinetics in Children With Bacterial Infections NCT00714402 | Shaare Zedek Medical Center | — |
| Completed | What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Prese NCT00736554 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Completed | Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers NCT00575367 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Bacteriophage Therapy of Difficult-to-treat Infections NCT05498363 | Queen Astrid Military Hospital | — |
| Completed | Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Rou NCT00575380 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years NCT00488345 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 2 |
| Completed | Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers NCT00564447 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia NCT00515034 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | Trial of Rapid Diagnostic Tests in Rural Ghana NCT00493922 | London School of Hygiene and Tropical Medicine | Phase 4 |
| Completed | PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA) NCT00472667 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity NCT00353158 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Phase 1 |
| Completed | Study Evaluation Tazocin Intervention NCT00488189 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Quinolone Resistance in Bloodstream Isolates of Escherichia Coli NCT00449735 | University of Pittsburgh | — |
| Completed | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infecti NCT00423657 | Forest Laboratories | Phase 3 |
| Completed | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infecti NCT00424190 | Forest Laboratories | Phase 3 |
| Completed | Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards NCT00431483 | Ludwig-Maximilians - University of Munich | N/A |
| Completed | Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Inf NCT00366249 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection NCT01074775 | St George's, University of London | N/A |
| Completed | Tazocin Intervention Study NCT00478855 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients NCT00410527 | National Institutes of Health Clinical Center (CC) | Phase 4 |
| Completed | Evaluation of Atuna Racemosa Toxicity NCT00318344 | Mayo Clinic | Phase 1 |
| Terminated | Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of A NCT00493038 | Bayer | Phase 4 |
| Unknown | Experimental Phage Therapy of Bacterial Infections NCT00945087 | Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences | N/A |
| Completed | Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization NCT00288418 | Angiotech Pharmaceuticals | Phase 3 |
| Terminated | Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery NCT00431028 | Federal University of São Paulo | Phase 1 / Phase 2 |
| Unknown | Contrast-Enhanced US of Spleen, Liver and Kidney NCT00190281 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Unfractioned Heparin for Treatment of Sepsis NCT00100308 | Universidad de Antioquia | Phase 3 |
| Completed | Therapeutic Zinc in Infant Bacterial Illness NCT00347386 | Centre For International Health | Phase 2 / Phase 3 |
| Completed | Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance NCT01788449 | Wyeth is now a wholly owned subsidiary of Pfizer | — |
| Completed | Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. NCT00216450 | Janssen Cilag Pharmaceutica S.A.C.I., Greece | Phase 4 |
| Completed | BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis NCT00670215 | Bayer | Phase 3 |
| Completed | Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens. NCT00205816 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Ciprofloxacin on Burned Patients NCT00668044 | Bayer | Phase 3 |
| Completed | Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection NCT00044928 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride NCT00515151 | University Hospital Freiburg | Phase 4 |
| Completed | Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria NCT00037050 | Pfizer | Phase 3 |
| Completed | New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant En NCT00035854 | Pfizer | Phase 3 |
| Completed | Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomona NCT00004747 | National Center for Research Resources (NCRR) | Phase 2 |
| Completed | A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complic NCT00258102 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 |
| Completed | A Study of Azithromycin in HIV-Infected Patients NCT00002344 | Pfizer | Phase 1 |
| Completed | Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines NCT00008853 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim NCT00000826 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. NCT00002139 | Pfizer | Phase 1 |
| Completed | A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children NCT00000811 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Approved For Marketing | Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections NCT03780140 | Shionogi | — |